1
Appetite reduction
May help reduce frequent hunger and support better portion control.
Ozempic Dubai | Semaglutide Medical Weight Support
Ozempic in Dubai
Doctor-led semaglutide review in Dubai with prescription guidance and metabolic care support.
ABOUT OZEMPIC
A weekly GLP-1 option for adults who need structured diabetes and metabolic care.
Ozempic is a prescription-based semaglutide injection used in medical care for eligible patients, including adults with type 2 diabetes. At MyCare in Dubai, Ozempic may be discussed only after a doctor-led review of your health profile, medical history, and treatment goals. Suitability, prescription guidance, side effects, and follow-up support should always be managed by a qualified healthcare professional.
Prescription required. Medical assessment is mandatory.
Ozempic® is not a general cosmetic weight-loss product. It must be prescribed and monitored by a licensed healthcare professional based on diagnosis, medical history, lab results, and treatment goals.
How it helps
Ozempic may support appetite control and metabolic health.
2
Better satiety
May help patients feel fuller with smaller meals when supported by a structured plan.
3
Blood sugar support
Supports glucose-related pathways, especially relevant for patients with type 2 diabetes or metabolic risk.
4
Weekly routine
Taken once weekly, which may be easier for some patients than daily treatment schedules.
Dose Pathway
Ozempic® is started low and adjusted carefully.
The dose must be prescribed by a doctor. Do not self-start, self-increase, or combine with other GLP-1 or incretin-based medicines without medical instruction.
| Dose | Common timing | Clinical purpose |
|---|---|---|
| 0.25mg once weekly | Usually first 4 weeks | Starting dose to help the body adjust. It is not typically considered the maintenance dose for glycemic control. |
| 0.5mg once weekly | Usually from week 5 | Common maintenance dose. Response, side effects, and glucose results are reviewed before any increase. |
| 1mg once weekly | After at least 4 weeks on 0.5mg, if needed | May be prescribed when additional glycemic control is required and clinically suitable. |
| 2mg once weekly | After at least 4 weeks on 1mg, if needed | Higher dose option for additional glycemic control. Weekly doses above 2mg are not recommended. |
0.25mg once weekly
Common timing
Usually first 4 weeks
Clinical purpose
Starting dose to help the body adjust. It is not typically considered the maintenance dose for glycemic control.
0.5mg once weekly
Common timing
Usually from week 5
Clinical purpose
Common maintenance dose. Response, side effects, and glucose results are reviewed before any increase.
1mg once weekly
Common timing
After at least 4 weeks on 0.5mg, if needed
Clinical purpose
May be prescribed when additional glycemic control is required and clinically suitable.
2mg once weekly
Common timing
After at least 4 weeks on 1mg, if needed
Clinical purpose
Higher dose option for additional glycemic control. Weekly doses above 2mg are not recommended.
Treatment suitability must be confirmed by a qualified doctor. Results and medication options vary by patient.
Why MyCare
Ozempic should be managed with medical follow-up, not taken casually.
Semaglutide can affect appetite, digestion, hydration, glucose levels, and medication tolerance. MyCare helps patients use it within a structured pathway that supports safety, nutrition, and long-term progress.
Doctor consultation
Prescription review
Health Snapshot™ screening
Dose and tolerance support
Side-effect management
Progress monitoring
Body composition tracking
Protein and hydration guidance
MyCare pathway
Ozempic® should be supported by a complete clinical plan.
MyCare’s role is to make treatment safer, clearer, and easier to follow through proper assessment, baseline screening, monitoring, education, and follow-up.
01
Doctor Assessment
Review diagnosis, goals, BMI, diabetes history, current medicines, and contraindications.
02
Screening Review
Check relevant bloodwork, kidney function, glucose markers, cardiovascular risk, and medication safety.
03
Prescription Plan
Confirm dose, titration, injection technique, side-effect guidance, and follow-up schedule.
04
Ongoing Monitoring
Track response, tolerance, glucose trends, weight changes, hydration, and treatment adherence.
SAFETY FIRST
Who should not use Ozempic® or needs extra caution?
Suitability must be confirmed by a licensed healthcare professional before treatment.
Do not use Ozempic® if you have:
We review your goals, symptoms, health history, medications, and expectations.
- Personal or family history of medullary thyroid carcinoma.
- Multiple Endocrine Neoplasia syndrome type 2.
- Known serious allergy to semaglutide or any ingredient in the product.
Tell the doctor before use if you have:
We review your goals, symptoms, health history, medications, and expectations.
- Pancreas, kidney, or gallbladder problems.
- Diabetic retinopathy or vision changes.
- Pregnancy, breastfeeding, or planned pregnancy.
- Use of insulin or sulfonylureas due to low blood sugar risk.
Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and constipation. Seek urgent medical advice for severe or persistent abdominal pain, repeated vomiting, signs of dehydration, allergic reaction symptoms, vision changes, severe hypoglycemia symptoms, neck swelling, trouble swallowing, or breathing difficulty.
FAQS
Ozempic Frequently Asked Questions
What is Ozempic?
Ozempic is a prescription-based semaglutide injection used in medical care for eligible patients, including adults with type 2 diabetes. At MyCare in Dubai, Ozempic may be discussed only after medical screening and doctor review.
Is Ozempic available in Dubai through MyCare?
MyCare can support eligible patients in Dubai with doctor-led assessment, screening guidance, prescription support, and follow-up care for Ozempic when clinically suitable.
Who may be suitable for Ozempic?
Suitability depends on your medical history, blood sugar profile, current medications, weight-related or metabolic risks, and doctor assessment. Ozempic is not suitable for everyone, so screening is required before starting.
Is Ozempic a weight loss injection?
Ozempic may be associated with weight changes in some patients, but it should not be treated as a general cosmetic weight loss injection. It must be reviewed by a doctor based on your health profile, diagnosis, and clinical suitability.
Is Ozempic the same as Wegovy or Mounjaro?
No. Ozempic and Wegovy both contain semaglutide, but their medical use and suitability may differ. Mounjaro contains tirzepatide. A doctor can explain which option may be appropriate for your profile.
Do I need a prescription for Ozempic in Dubai?
Yes. Ozempic should only be used after medical assessment and prescription guidance. MyCare follows a doctor-led process to help assess suitability, safety, dosage guidance, and follow-up needs.
What follow-up is needed during Ozempic treatment?
Follow-up may include progress checks, blood sugar review where relevant, side-effect review, prescription guidance, nutrition support, and health monitoring. Regular follow-up helps the doctor assess whether treatment remains suitable.
RELATED OPTIONS
Compare Ozempic with other doctor-supervised options.
Explore other prescription-based GLP-1 and weight management options available through MyCare in Dubai. Each option is reviewed with medical screening, doctor guidance, and follow-up support when clinically suitable.
Foundayo GLP-1 Pill
Prescription required
Wegovy Pill
Prescription required
Wegovy Pen
Prescription required
Mounjaro
Prescription required
GET STARTED TODAY
We’re here to support your
health journey.
Speak to our care team to ask questions, check your eligibility, and take the first step toward a healthier you.
Your health information is safe and confidential.